Montelukast: Difference between revisions
No edit summary |
CSV import |
||
| Line 15: | Line 15: | ||
{{antiasthma drugs}} | {{antiasthma drugs}} | ||
{{coststubd}} | {{coststubd}} | ||
<gallery> | |||
File:Montelukast.svg|Montelukast | |||
File:Montelukast 3D ball-and-stick.png|Montelukast 3D ball-and-stick | |||
</gallery> | |||
Revision as of 01:28, 20 February 2025
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma. It is marketed as Singulair.
Information about Montelukast
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
Liver safety of Montelukast
It has been linked to rare cases of clinically apparent liver injury.
Mechanism of action of Montelukast
Montelukast (mon" te loo' kast) is a leukotriene receptor antagonist that binds to the CysLT1 and CysLT2 receptors, thereby interfering with inflammatory pathways that are involved in the pathogenesis of asthma and allergic rhinitis. Montelukast has been shown to reduce symptoms of asthma and allergic rhinitis and prevent acute attacks.
FDA approval information for Montelukast
Montelukast was approved for use in the United States in 1998 and is widely used with more than 20 million prescriptions being filled yearly. Current indications for montelukast include prophylaxis and chronic treatment of asthma, prevention of exercise induced bronchoconstriction and allergic rhinitis.
Dosage and administration for Montelukast
Montelukast is available in several generic forms and under the commercial name Singulair. The recommended dosage for adults is 10 mg once daily. Lower doses and chewable tablets are recommended for pediatric patients.
Side effects of Montelukast
Common side effects include dyspepsia, abdominal discomfort, asthenia, headache, dizziness, fatigue and fever.
|
|
|
Albuterol, Bitolterol, Formoterol, Metaproterenol, Pirbuterol, Salbutamol, Salmeterol, Terbutaline
Leukotriene Receptor Antagonists
Benralizumab, Mepolizumab, Omalizumab, Reslizumab
-
Montelukast
-
Montelukast 3D ball-and-stick


